Biologicals

BCG

WHO Informal Consultation on Standardization and Evaluation of BCG Vaccines

WHO, Geneva, Switzerland, 22-23 September 2009

WHO Discussion on the improvement of the quality control of BCG vaccines

Pasteur Institute, Paris, France, 7 June 2005

WHO Consultation on the characterization of BCG vaccines

WHO, Geneva, Switzerland, 8-9 December 2004

BCG vaccine WHO Consultation on the characterization of BCG strains

London, 15-16 December 2003

ESSENTIAL MEDICINES AND HEALTH PRODUCTS



NEW PUBLICATIONS

UPCOMING EVENTS


  • WHO Informal Consultation on development of guidelines on procedures and data requirements for changes to approved biotherapeutic products including biosimilars, Seoul, Republic of Korea, 27-28 April 2017
  • Working Group meeting on revision of WHO TRS 941, Annex 5: WHO biosafety risk assessment and Guidelines for the production and quality control of human influenza pandemic vaccines, Geneva, Switzerland, 9-10 May 2017
  • Working group meeting on Hepatitis E Vaccine, Geneva, Switzerland, 11-12 May 2017

Contacts


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971